United States· US:51655-511_4b47a2d1-9d96-fbd6-e063-6294a90a5fe1
Buspirone Hydrochloride
A buspirone product containing buspirone hydrochloride, registered in United States by Northwind Health Company, LLC. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Buspirone is registered in 12 of 19 countries.
Countries holding a registration under ATC N05BE01 (buspirone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Buspirone · ATC N05BE01
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of buspirone costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Buspirone · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- FR France$0.60
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BUSPIRONE HYDROCHLORIDE
- Manufacturer
- Northwind Health Company, LLC
- Country
- United States (US)
- ATC code
- N05BE01
- ATC class
- Buspirone
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11516555115230 TABLET in 1 BOTTLE, PLASTIC (51655-511-52)
- ndc1151655-511-52
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
258 interactions on record for buspirone.
Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Buspirone · interactions on record
258 records
- 22 severe
- 118 moderate
- 118 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Buspirone in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBuspirone 7.5mg tabletsStrides Pharma UK Ltd
- SwedenAnksilon 10 mg TablettOrion Corporation
- FinlandAnksilonOrion Corporation
- CanadaAMB-BUSPIRONEAMBICARE PHARMACEUTICALS INC.
- PolandSpamilanInPharm Sp. z o.o.
- NorwayBuripal2care4 Generics ApS
- CzechiaBUSPIRON-EGISEgis Pharmaceuticals PLC, Budapešť
- NetherlandsBuspiron HCl CF 10 mg, tablettenCentrafarm B.V.
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Czechia · Buspiron-Egis
- Germany · Busp
- Denmark · Buripal, Buspiron Actavis
- Finland · Anksilon, Buspiron Ratiopharm
- France · Buspirone Sandoz, Buspirone Viatris
- United Kingdom (Northern Ireland) · Buspirone Accord-Uk, Buspirone Hydrochloride
- Greece · Antipsichos, Bergamol
- Hungary · Spitomin
- Lithuania · Spitomin
- Latvia · Spitomin
- Netherlands · Buspiron Hcl Cf, Buspiron Hcl Mylan
- Norway · Buripal, Buspirone Orion
- Poland · Spamilan
- Portugal · Ansiten, Busansil
- Romania · Spitomin
- Sweden · Anksilon, Buripal
- Slovakia · Spitomin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9ff3867-fbe8-474f-820f-2f396f8948fe GET /v1/drugs/a9ff3867-fbe8-474f-820f-2f396f8948fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "7.5",
"substance": "BUSPIRONE HYDROCHLORIDE",
"productndc": "51655-511",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA202557",
"marketing_category": "ANDA"
}See everything about buspirone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.